ZYLOX-Tonbridge Medical has achieved a key milestone with the regulatory approval of its Unicorn™ Vascular Closure Device in Indonesia, marking the product’s official entry into the Southeast Asian market. This approval demonstrates the region’s recognition of the device’s safety and clinical value and supports the company’s broader internationalization strategy. The Unicorn™ is engineered to deliver precise, efficient vascular closure following interventional procedures, positioning it as a vital advancement in post-operative care.

Designed with proprietary technology, the Unicorn™ device offers minimally invasive arterial closure using a bioresorbable anchor and suture-based mechanism. It reduces time to hemostasis and enhances patient mobility and comfort by minimizing complications like bleeding or infection. These features make it particularly suitable for hospitals and clinics aiming to improve procedural efficiency and post-surgical recovery outcomes, especially in high-volume cardiovascular and neurovascular centers.